Studied in the published literature on energy balance, glucose handling and hepatic lipid metabolism
Others may need multiple small meals or added snacks to get enough calories, protein, fiber, vitamins and minerals, say registered dietitians and authors of The GLP-1 Diet Cookbook, Marie Feldman and Jodi Dalyai
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity Sean Wharton Ildiko Lingvay Pawel Bogdanski Ruben Duque do Vale Stephan Jacob Tobias Karlsson Chaithra Shaji Domenica Rubino Timothy W
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
What Semaglutide Provides Clinical trials demonstrate significant cardiovascular benefits: Event reduction: The SELECT trial showed 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) with semaglutide in patients with obesity and established heart disease